Jorizzo JL - Search Results

1

Retrospective analysis of ocular adverse events with Clobetasol.

Wang Y, Jorizzo JL. Wang Y, et al. Among authors: jorizzo jl. Dermatol Ther. 2022 Jul;35(7):e15574. doi: 10.1111/dth.15574. Epub 2022 May 29. Dermatol Ther. 2022. PMID: 35567355 Free PMC article. No abstract available.

2

Analysis of utilization, cost and prescription trends of mycophenolate mofetil and methotrexate among medicare patients.

Wang Y, Jorizzo J. Wang Y, et al. J Dermatolog Treat. 2022 May;33(3):1798-1799. doi: 10.1080/09546634.2021.1886229. Epub 2021 Jul 14. J Dermatolog Treat. 2022. PMID: 33554688 Free article. No abstract available.

3

Difference in the rate of ocular adverse events with dupilumab between asthma and atopic dermatitis patients.

Wang Y, Jorizzo J. Wang Y, et al. Int J Dermatol. 2021 Sep;60(9):e382. doi: 10.1111/ijd.15524. Epub 2021 Mar 14. Int J Dermatol. 2021. PMID: 33715168 No abstract available.

4

Retrospective analysis of adverse events with dupilumab reported to the United States Food and Drug Administration.

Wang Y, Jorizzo JL. Wang Y, et al. Among authors: jorizzo jl. J Am Acad Dermatol. 2021 Apr;84(4):1010-1014. doi: 10.1016/j.jaad.2020.11.042. J Am Acad Dermatol. 2021. PMID: 33725800

5

Retrospective analysis of adverse events with mycophenolate mofetil and methotrexate when used for dermatologic indications.

Wang Y, Jorizzo J. Wang Y, et al. Int J Dermatol. 2022 Jul;61(7):e275-e276. doi: 10.1111/ijd.15767. Epub 2021 Jul 2. Int J Dermatol. 2022. PMID: 34212376 No abstract available.

6

Retrospective analysis of ocular adverse events with topical hydrocortisone when used for dermatologic indications.

Wang Y, Jorizzo J. Wang Y, et al. Dermatol Ther. 2022 Jan;35(1):e15178. doi: 10.1111/dth.15178. Epub 2021 Nov 14. Dermatol Ther. 2022. PMID: 34708507 No abstract available.

7

Ocular adverse events associated with topical corticosteroid use in dermatology: A systematic review.

Ricardo JW, Wang Y, Haidari W, Jorizzo JL. Ricardo JW, et al. Among authors: jorizzo jl. J Am Acad Dermatol. 2023 Apr;88(4):897-898. doi: 10.1016/j.jaad.2022.10.026. Epub 2022 Oct 15. J Am Acad Dermatol. 2023. PMID: 36252686 No abstract available.

8

Retrospective analysis of risks and benefits of trimethoprim/sulfamethoxazole as prophylaxis for Pneumocystis jiroveci pneumonia in patients with dermatologic disease.

Moumen M, Andrews LA, Wang Y, Haidari W, Jorizzo JL. Moumen M, et al. Among authors: jorizzo jl. J Am Acad Dermatol. 2023 Jun;88(6):1392-1393. doi: 10.1016/j.jaad.2023.01.041. Epub 2023 Feb 15. J Am Acad Dermatol. 2023. PMID: 36796726 No abstract available.

9

Clobetasol propionate emollient 0.05 percent: hypothalamic-pituitary-adrenal-axis safety and four-week clinical efficacy results in plaque-type psoriasis.

Jorizzo JL, Magee K, Stewart DM, Lebwohl MG, Rajagopalan R, Brown JJ. Jorizzo JL, et al. Cutis. 1997 Jul;60(1):55-60. Cutis. 1997. PMID: 9252738 Clinical Trial.

10

Small-vessel vasculitis.

Kinney MA, Jorizzo JL. Kinney MA, et al. Among authors: jorizzo jl. Dermatol Ther. 2012 Mar-Apr;25(2):148-57. doi: 10.1111/j.1529-8019.2012.01535.x. Dermatol Ther. 2012. PMID: 22741934

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters